ArticleMolecular medicine (Cambridge, Mass.)2024

Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes.

Yuan Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.